Maze Therapeutics (NASDAQ:MAZE) outlined positive Phase II results from its open-label HORIZON study evaluating MZE829 in ...

Proteinuria is a condition characterised by the presence of excess protein, mainly albumin, in the urine. Generally, the kidneys filter waste products and excess fluids from the blood and excrete them ...

Maze Therapeutics stock crashed Wednesday despite "overwhelmingly positive" test results for a kidney disease drug.

Proteinuria is common in the adult population and its clinical significance can vary widely. A clear diagnostic process is needed to identify the cause of the findings and guide the treatment ...

Please provide your email address to receive an email when new articles are posted on . Remission of proteinuria to less than 0.3 g per day was linked to greater eGFR preservation for patients with ...

Please provide your email address to receive an email when new articles are posted on . Including the duration of proteinuria remission may better predict which patients with IgA nephropathy will ...

Increased risk of sudden cardiac arrest in younger adults with proteinuria was higher in those with chronic kidney disease. Proteinuria is associated with higher risk of sudden cardiac arrest in ...